DNA Operating Cash Flow (Statement)
Ginkgo Bioworks Holdings Inc Class · Operating Cash Flow (Statement)
DNA Operating Cash Flow (Statement)
Latest reported-$44.27Mperiod ending
DNA Quarterly Cash from Operations (-$24.01M → -$44.27M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
DNA operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -44,273,000 | |
| -46,686,000 | |
| -47,678,000 | |
| -31,606,000 | |
| -40,254,000 | |
| -51,521,000 | |
| -42,435,000 | |
| -103,501,000 | |
| -84,390,000 | |
| -89,259,000 | |
| -57,831,000 | |
| -73,551,000 | |
| -73,533,000 | |
| -90,585,000 | |
| -104,531,000 | |
| -28,472,000 | |
| -99,297,000 | |
| -19,898,000 | |
| -165,541,000 | |
| -5,235,000 | |
| -34,911,000 | |
| -48,131,000 | |
| -59,339,000 | |
| -25,270,000 | |
| -27,209,000 | |
| -24,012,000 |